Molecular Alterations of the Endocannabinoid System in Psychiatric Disorders

Autor: Navarro D, Gasparyan A, Navarrete F, Torregrosa AB, Rubio G, Marín-Mayor M, Acosta GB, Garcia-Gutiérrez MS, Manzanares J

Publikováno v: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
instname

The therapeutic benefits of the current medications for patients with psychiatric disorders contrast with a great variety of adverse effects. The endocannabinoid system (ECS) components have gained high interest as potential new targets for treating

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::ccb0eac990bcd3496188b937f1c3a540
https://fundanet.isabial.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=8938